Search | Page 36 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. T-cell Depleted Alternative Donor Transplantation

    ... disease (GVHD) in patients receiving a stem cell transplant from an alternative (unrelated and mismatched related) ... and post-transplant infections. Patients requiring stem cell transplants for either malignant (cancerous) or non-malignant disease ... Device: CliniMACS® (T cell depletion) Stem cells will be collected from donors after they receive Granulocyte ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.

  2. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... RATIONALE: Midostaurin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in ... patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  3. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy, or ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  4. Kathryn (Kate) Bauer, Retired MDS Patient Living Life to the Fullest Since Transplant

    ... and it showed something was off with my white and red blood cells. I had a repeat blood test in September and it improved slightly, but my ... as my primary caregiver. In January 2011, I received a stem cell bone marrow transplant from an unrelated donor from the ...

    Patient Chronicle last updated 07/23/2015 - 9:38am.

  5. Clinical Trials Report for April 2014

    ... treated with drugs that suppress the immune system or with stem cell transplant. People with SAA who receive these treatments are more ... Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells ...

    Page last updated 04/18/2014 - 3:36pm.

  6. 2014 Bone Marrow Failure Disease Symposia - Penn State College of Medicine

    ... with Umbilical Cord Blood and Haploidentical Stem Cells : A new and effective Treatment option for patients with ... Witold B. Rybka, MD, Professor and Director, Stem Cell Transplant Program Penn State Hershey Cancer Institute, ...

    Page last updated 10/29/2014 - 3:39pm.

  7. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the immunomodulating drug, ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  8. Interviews with the Experts: Side Effects of PNH Treatment

    ... caused by PNH. It may also increase counts of white blood cells and platelets in some people. Prednisone may not be effective in ... of medicine and pathology, Section of Hematology and Stem Cell Transplantation, Division of Hematology/Oncology, at Rush University ...

    Interview last updated 08/31/2016 - 8:37am.

  9. Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

    ... salvage therapy, or has relapsed after hematopoietic stem cell transplant (HSCT). Participant disease tested positive for ... on Day 8 of the first cycle. If they do not have leukemia cells in their spinal fluid, they will receive only one IT chemotherapy per ...

    Clinical Trial last updated 06/06/2016 - 10:04am.

  10. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... with hematologic malignancies undergoing hematopoietic stem cell transplant (HSCT). Biological therapies, such as sirolimus and ... suppress the immune system in different ways and stop tumor cells from growing. Giving sirolimus and mycophenolate mofetil after ...

    Clinical Trial last updated 05/03/2016 - 11:35am.